You are viewing an expired study

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

San Antonio, Texas 78284

  • Related Disorders

Purpose:

The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.


Study summary:

The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.


Criteria:

Inclusion Criteria: - Cocaine dependent, non treatment seeking individuals Exclusion Criteria: Please contact site directly for details.


Study is Available At:


Original ID:

NIDA-CTO-0013-1


NCT ID:

NCT00040066


Secondary ID:


Study Acronym:


Brief Title:

Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1


Official Title:

Development of Human Laboratory Study Model of Cocaine Relapse Prevention


Overall Status:

Unknown status


Study Phase:

Phase 1


Genders:

Both


Minimum Age:

18 Years


Maximum Age:

55 Years


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

National Institute on Drug Abuse (NIDA)


Oversight Authority:

United States: Food and Drug Administration


Reasons Why Stopped:


Study Type:

Interventional


Study Design:

Intervention Model: Parallel Assignment, Masking:


Number of Arms:

0


Number of Groups:

0


Total Enrollment:

32


Enrollment Type:


Overall Contact Information

Official Name:John Roache, Ph.D.
Principal Investigator
National Institute on Drug Abuse (NIDA)

Study Dates

Start Date:May 2002
Completion Date:August 2003
Verification Date:September 2004
Last Changed Date:January 10, 2017
First Received Date:June 18, 2002

Study Outcomes

Outcome Type:Primary Outcome
Measure:Cocaine craving
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Cocaine related high
Safety Issues:False

Study Interventions

Intervention Type:Procedure
Name:Cocaine (IV)

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:NIH
Agency Type:Lead Sponsor
Agency Name:National Institute on Drug Abuse (NIDA)

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.